117 related articles for article (PubMed ID: 29423120)
21. Prognositic value of CD73-adenosinergic pathway in solid tumor: A meta-analysis and systematic review.
Wang R; Zhang Y; Lin X; Gao Y; Zhu Y
Oncotarget; 2017 Aug; 8(34):57327-57336. PubMed ID: 28915673
[TBL] [Abstract][Full Text] [Related]
22. Expression of autophagy-related factor p62 for lung cancer diagnosis and prognosis: A systematic review and meta-analysis.
Wang BJ; Tang YD; Yu BY; Gui D; Xu H
Math Biosci Eng; 2019 Jul; 16(6):6805-6821. PubMed ID: 31698589
[TBL] [Abstract][Full Text] [Related]
23. Astrocyte Elevated Gene-1 as a Novel Clinicopathological and Prognostic Biomarker for Gastrointestinal Cancers: A Meta-Analysis with 2999 Patients.
Luo Y; Zhang X; Tan Z; Wu P; Xiang X; Dang Y; Chen G
PLoS One; 2015; 10(12):e0145659. PubMed ID: 26710214
[TBL] [Abstract][Full Text] [Related]
24. C-Met as a potential novel prognostic marker in squamous cell carcinoma and adenocarcinoma of esophagus: evidence from a meta-analysis.
Ren JL; Wu HF; Wang WJ; Hu GM; Gu B; Zhang M; Wang YX
Panminerva Med; 2017 Mar; 59(1):97-106. PubMed ID: 27636117
[TBL] [Abstract][Full Text] [Related]
25. Association between raf kinase inhibitor protein loss and prognosis in cancers of the digestive system: a meta-analysis.
Yu M; Wang Q; Ding JW; Yang Z; Xie C; Lu NH
Cancer Biomark; 2014; 14(5):389-400. PubMed ID: 25171481
[TBL] [Abstract][Full Text] [Related]
26. Cytoplasmic SQSTM1/ P62 Accumulation Predicates a Poor Prognosis in Patients with Malignant Tumor.
Zhu L; Wang Y; He J; Tang J; Lv W; Hu J
J Cancer; 2018; 9(21):4072-4086. PubMed ID: 30410612
[No Abstract] [Full Text] [Related]
27. Prognostic value of decreased long non-coding RNA TUSC7 expression in some solid tumors: a systematic review and meta-analysis.
Li N; Yang M; Shi K; Li W
Oncotarget; 2017 Aug; 8(35):59518-59526. PubMed ID: 28938655
[TBL] [Abstract][Full Text] [Related]
28. Pooling-analysis for diagnostic and prognostic value of MiRNA-100 in various cancers.
Dou Z; Lin S; Dai C; Lu Y; Tian T; Wang M; Liu X; Zheng Y; Xu P; Li S; Sheng Q; Deng Y; Dai Z
Oncotarget; 2017 Sep; 8(37):62703-62715. PubMed ID: 28977982
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of cytokeratin 19 in hepatocellular carcinoma: A meta-analysis.
Sun DW; Zhang YY; Sun XD; Chen YG; Qiu W; Ji M; Lv GY
Clin Chim Acta; 2015 Aug; 448():161-9. PubMed ID: 26164382
[TBL] [Abstract][Full Text] [Related]
30. Fibroblast activation protein overexpression and clinical implications in solid tumors: a meta-analysis.
Liu F; Qi L; Liu B; Liu J; Zhang H; Che D; Cao J; Shen J; Geng J; Bi Y; Ye L; Pan B; Yu Y
PLoS One; 2015; 10(3):e0116683. PubMed ID: 25775399
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Value of XIAP Level in Patients with Various Cancers: A Systematic Review and Meta-Analysis.
Gao X; Zhang L; Wei Y; Yang Y; Li J; Wu H; Yin Y
J Cancer; 2019; 10(6):1528-1537. PubMed ID: 31031863
[No Abstract] [Full Text] [Related]
32. Clinicopathologic and Prognostic Value of Serum Carbohydrate Antigen 19-9 in Gastric Cancer: A Meta-Analysis.
Song YX; Huang XZ; Gao P; Sun JX; Chen XW; Yang YC; Zhang C; Liu HP; Wang HC; Wang ZN
Dis Markers; 2015; 2015():549843. PubMed ID: 26576068
[TBL] [Abstract][Full Text] [Related]
33. Impact of estrogen receptor-β expression on breast cancer prognosis: a meta-analysis.
Liu J; Guo H; Mao K; Zhang K; Deng H; Liu Q
Breast Cancer Res Treat; 2016 Feb; 156(1):149-62. PubMed ID: 26902609
[TBL] [Abstract][Full Text] [Related]
34. Clinicalpathological and prognostic significance of survivin expression in renal cell carcinoma: a meta-analysis.
Pu Z; Wang Q; Xie H; Wang G; Hao H
Oncotarget; 2017 Mar; 8(12):19825-19833. PubMed ID: 28178644
[TBL] [Abstract][Full Text] [Related]
35. Prognostic Value of Circulating Tumor Cells in Ovarian Cancer: A Meta-Analysis.
Zhou Y; Bian B; Yuan X; Xie G; Ma Y; Shen L
PLoS One; 2015; 10(6):e0130873. PubMed ID: 26098665
[TBL] [Abstract][Full Text] [Related]
36. Transducin (β)-like 1 X-linked receptor 1 correlates with clinical prognosis and clinicopathological characteristics in human solid carcinomas.
Liu F; Gao H; Zhao Y; Zhu Z
Oncotarget; 2017 Sep; 8(37):61626-61636. PubMed ID: 28977891
[TBL] [Abstract][Full Text] [Related]
37. The Prognostic and Clinicopathological Significance of Tumor-Associated Macrophages in Patients with Gastric Cancer: A Meta-Analysis.
Yin S; Huang J; Li Z; Zhang J; Luo J; Lu C; Xu H; Xu H
PLoS One; 2017; 12(1):e0170042. PubMed ID: 28081243
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of YKL-40 in solid tumors: a meta-analysis of 41 cohort studies.
Bian B; Li L; Yang J; Liu Y; Xie G; Zheng Y; Zeng L; Zeng J; Shen L
Cancer Cell Int; 2019; 19():259. PubMed ID: 31624472
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Values of TIM-3 Expression in Patients With Solid Tumors: A Meta-Analysis and Database Evaluation.
Qin S; Dong B; Yi M; Chu Q; Wu K
Front Oncol; 2020; 10():1288. PubMed ID: 32850398
[No Abstract] [Full Text] [Related]
40. Prognostic value of rsf-1/hbxap in human solid tumors: a meta-analysis of cohort studies.
Wu J; Hu L; Wu F; He T
Int J Clin Exp Med; 2015; 8(2):1944-55. PubMed ID: 25932123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
